To include your compound in the COVID-19 Resource Center, submit it here.

Adderall XR: Phase IIIb data; marketed

In an open-label U.S. Phase IIIb trial in 2,968 patients, switching to Adderall XR from other medications

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE